METHODS

Design:
Randomised controlled non-inferiority trial. Allocation: Concealed. Blinding: Single blinded (outcome assessors blinded). Follow up period: 5 months (including 2-month treatment period).
MAIN RESULTS
Perprotocol analysis of the primary outcome showed that SPARX was not inferior to usual care both post-treatment and 3 months later, and this was supported by intention-to-treat analysis. Post-treatment there was no significant difference between SPARX and usual care in change in depressions symptoms, (mean reduction in CDRS-R: 10.32 with SPARX vs 7.59 points with usual care; mean difference: +2.73; 95% CI −0.31 to +5.77, p=0.079). Intention-to-treat analysis also found no significant difference in change in severity of depression with SPARX group compared to usual care posttreatment (mean reduction in CDRS-R: 9.05 with SPARX vs 7.45 with usual care; mean difference: +1.60, 95% CI −1.21 to +4.41, p=0.264). At 3-month post-treatment follow-up, there was still no significant difference between SPARX and usual care for the primary outcome (perprotocol mean difference in CDRS-R change: −1.28, 95% CI −4.35 to +1.79, p=0.412; intention-to-treat mean difference: −0.75, 95% CI −3.62 to +2.12, p=0.609). COMMENTARY M erry and colleagues correctly note that although there is clear evidence of the effectiveness of computerised self-help programs for adults with depression, little is known about the effectiveness of such programs for their adolescent counterparts. This is surprising given the high level of depression among young people, their low level of formal help seeking for depression and the high degree of IT literacy and IT uptake in this age group. Accordingly, the authors developed a computerised cognitive behavioral therapy fantasy game, SPARX, designed to be engaging to young people and evaluated its effectiveness in a multicentre non-inferiority randomised-controlled trial, employing a treatment as usual control and 3-month follow-up. The primary, intention-to-treat, finding was that the reduction in depression symptoms, response rate and remission levels associated with SPARX was at least as great as that seen among adolescents who accessed standard primary healthcare. This finding could have significant policy and practice implications for the delivery of mental healthcare to adolescents. It suggests that SPARX may represent a low-cost alternative to standard primary care for many young people. However, a limitation of the study is that there is no way of knowing if the primary healthcare services themselves were effective. Control participants received usual care in primary care settings with most participants receiving 'counselling'. However, there is no description of the nature of this counselling, whether it involved the delivery of evidence-based treatments or the qualifications of those providing it. Apart from some isolated findings, there was little evidence that SPARX was significantly superior to usual care over 3 months. Thus, although it can be concluded that on average participants would not be worse off receiving SPARX, more data are needed to be sure that the intervention works in these settings. That said, the findings are encouraging, the high level of self-reported adherence in a self-guided programme impressive, and the authors have previously reported pilot findings that suggested that SPARX was more effective than a wait-list control for adolescents 'excluded from mainstream education'. We await more evidence of the effectiveness of this promising programme.
Kathleen Margaret Griffiths
Centre for Mental Health Research, The Australian National University, Canberra, Australia
